ID28463A - KOMPOSISI DENGAN KEMURNIAN TINGGI YANG TERDIRI DARI (7α, 17α)-17-HIDROKSI-7-METIL-19-NOR-17-PREGN-5(10)-EN-20-IN-3-ON - Google Patents

KOMPOSISI DENGAN KEMURNIAN TINGGI YANG TERDIRI DARI (7α, 17α)-17-HIDROKSI-7-METIL-19-NOR-17-PREGN-5(10)-EN-20-IN-3-ON

Info

Publication number
ID28463A
ID28463A IDW20010850A ID20010850A ID28463A ID 28463 A ID28463 A ID 28463A ID W20010850 A IDW20010850 A ID W20010850A ID 20010850 A ID20010850 A ID 20010850A ID 28463 A ID28463 A ID 28463A
Authority
ID
Indonesia
Prior art keywords
pregn
hydroxy
methyl
composition
high purity
Prior art date
Application number
IDW20010850A
Other languages
English (en)
Inventor
Peter Kirchholtes
Gerard Arnoud J M T Sas
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8234220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID28463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID28463A publication Critical patent/ID28463A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IDW20010850A 1998-10-16 1999-10-11 KOMPOSISI DENGAN KEMURNIAN TINGGI YANG TERDIRI DARI (7α, 17α)-17-HIDROKSI-7-METIL-19-NOR-17-PREGN-5(10)-EN-20-IN-3-ON ID28463A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203460 1998-10-16

Publications (1)

Publication Number Publication Date
ID28463A true ID28463A (id) 2001-05-24

Family

ID=8234220

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010850A ID28463A (id) 1998-10-16 1999-10-11 KOMPOSISI DENGAN KEMURNIAN TINGGI YANG TERDIRI DARI (7α, 17α)-17-HIDROKSI-7-METIL-19-NOR-17-PREGN-5(10)-EN-20-IN-3-ON

Country Status (30)

Country Link
US (3) US6969708B1 (id)
EP (2) EP1121375B1 (id)
JP (1) JP2002527525A (id)
KR (3) KR100635018B1 (id)
CN (2) CN100432093C (id)
AR (1) AR020832A1 (id)
AT (1) ATE239032T1 (id)
AU (1) AU763232B2 (id)
BR (1) BR9914441A (id)
CA (1) CA2344686C (id)
CO (1) CO5160271A1 (id)
CZ (1) CZ298703B6 (id)
DE (1) DE69907495T2 (id)
DK (1) DK1121375T3 (id)
ES (1) ES2197677T3 (id)
HK (1) HK1039620B (id)
HU (1) HUP0104206A3 (id)
ID (1) ID28463A (id)
IL (1) IL141850A (id)
NO (1) NO317427B1 (id)
NZ (1) NZ510501A (id)
PE (1) PE20001377A1 (id)
PL (1) PL197870B1 (id)
PT (1) PT1121375E (id)
RU (1) RU2220975C2 (id)
SK (1) SK284569B6 (id)
TR (2) TR200101083T2 (id)
TW (2) TW200403251A (id)
WO (1) WO2000023460A1 (id)
ZA (1) ZA200101952B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356465A1 (en) * 2002-10-04 2004-04-05 ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
LT2662380T (lt) * 2005-02-01 2019-03-12 Atnahs Pharma Uk Limited Ibandronato polimorfo a medicininis panaudojimas
EP2610261A1 (en) 2005-02-01 2013-07-03 F. Hoffmann-La Roche AG Ibandronate polymorph B
EP1883648A1 (en) * 2005-05-23 2008-02-06 Newchem S.p.A. Process for the preparation of pure crystalline tibolone
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
AU2019401576A1 (en) * 2018-12-17 2021-06-24 Société des Produits Nestlé S.A. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (id) * 1964-06-16
CH488682A (de) * 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
NL146838B (nl) * 1966-06-24 1975-08-15 Organon Nv Werkwijze voor het bereiden van (delta)5(10)-3- keto-19-norsteroiden.
US3515719A (en) * 1967-03-15 1970-06-02 Upjohn Co 7-methyl-6,19-epoxy steroids of the androstane series
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
EP0406279A1 (en) * 1988-03-25 1991-01-09 Akzo N.V. Pharmaceutical preparation containing a fluoride salt
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
EP0613687B1 (en) * 1993-03-05 1999-06-02 Akzo Nobel N.V. Use of a pregnane derivatives for the treatment of tumours
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
IL123422A (en) * 1997-03-05 2003-05-29 Akzo Nobel Nv USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable

Also Published As

Publication number Publication date
CA2344686A1 (en) 2000-04-27
NO20011664L (no) 2001-04-03
CO5160271A1 (es) 2002-05-30
US20050245496A1 (en) 2005-11-03
PT1121375E (pt) 2003-07-31
DE69907495T2 (de) 2004-05-06
CN1322210A (zh) 2001-11-14
HUP0104206A2 (hu) 2002-04-29
EP1275379A2 (en) 2003-01-15
BR9914441A (pt) 2001-06-26
CN1769293A (zh) 2006-05-10
ATE239032T1 (de) 2003-05-15
AU763232B2 (en) 2003-07-17
NO317427B1 (no) 2004-10-25
CN100432093C (zh) 2008-11-12
CZ2001976A3 (cs) 2001-08-15
NZ510501A (en) 2003-10-31
PL347264A1 (en) 2002-03-25
CZ298703B6 (cs) 2007-12-27
JP2002527525A (ja) 2002-08-27
AR020832A1 (es) 2002-05-29
HUP0104206A3 (en) 2002-06-28
IL141850A (en) 2005-11-20
US6969708B1 (en) 2005-11-29
EP1275379A3 (en) 2003-03-26
EP1121375A1 (en) 2001-08-08
KR20060071897A (ko) 2006-06-27
KR100635018B1 (ko) 2006-10-17
RU2220975C2 (ru) 2004-01-10
TW200403251A (en) 2004-03-01
SK4932001A3 (en) 2001-12-03
TW577893B (en) 2004-03-01
PL197870B1 (pl) 2008-05-30
CN100378116C (zh) 2008-04-02
CA2344686C (en) 2009-04-28
ZA200101952B (en) 2002-06-10
KR20010080133A (ko) 2001-08-22
HK1039620B (en) 2003-08-22
SK284569B6 (sk) 2005-06-02
WO2000023460A1 (en) 2000-04-27
PE20001377A1 (es) 2000-12-09
KR20050003358A (ko) 2005-01-10
NO20011664D0 (no) 2001-04-03
AU6202999A (en) 2000-05-08
EP1121375B1 (en) 2003-05-02
US20040248870A1 (en) 2004-12-09
TR200101083T2 (tr) 2001-08-21
DK1121375T3 (da) 2003-08-04
HK1039620A1 (en) 2002-05-03
TR200504091T2 (tr) 2006-05-22
ES2197677T3 (es) 2004-01-01
IL141850A0 (en) 2002-03-10
DE69907495D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
ID30115A (id) Komposisi eplerenon yang dimikronisasi
ID28329A (id) Komposisi-komposisi yang sesuai untuk sel-sel elektrokimia
EP1016400A4 (en) COMPOSITION FOR EXTERNAL USE
IL174917A0 (en) Compounds useful as anti-inflammatory agents
EP1171801A4 (en) LIGHT-SENSITIVE COMPOSITIONS WITH POLYBENZOZAZOLE PREPARATIONS
HRP20000782B1 (en) New 3-aryl-2-hydroxypropionic acid derivative (i)
EP1096316A4 (en) POSITIVELY WORKING RESIST COMPOSITION
SG71202A1 (en) Photoresist compositions
GB9907122D0 (en) Improvements relating to lighting
GB0021654D0 (en) Not available at present
PL347264A1 (en) High purity composition comprising (7α,17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one
ID23371A (id) Pemulihan heksametilenediamina dari campuran-campuran yang sama
EP1031880A4 (en) POSITIVE RADIATION-SENSITIVE COMPOSITION
GB9826555D0 (en) Microemulsion compositions
SG78400A1 (en) Negative photoresist composition
PL342165A1 (en) Antienzymic composition containing ethylenediamino disuscinic acid
PL342628A1 (en) Pharmacological compositions
GB9810656D0 (en) Stable ammonium compositions
GB9801583D0 (en) Anti-snore gargle composition
EP1085080A4 (en) SURFACTANT COMPOSITION
AU1784899A (en) Nasal drop compositions
AU2115499A (en) 1,1,1,3,3-pentafluoropropane compositions
GB9819600D0 (en) Chemical compositions
GB0022726D0 (en) Not available at present
PL327711A1 (en) Electrode composition